NNK EFFECTS ON RECEPTOR PATHWAYS IN LUNG CELLS
NNK EFFECTS ON RECEPTOR PATHWAYS IN LUNG CELLS
批准号:
2467272
负责人:
Hildegard M. Schuller
金额:
$6.46万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 1997-12-31
中文摘要
描述:神经内分泌癌和外周腺癌是最常见的恶性肿瘤。
最常见的肺癌组织类型与吸烟有关。 的
烟碱衍生的亚硝胺,4-(甲基亚硝胺基)-1-(2-吡啶基)-1-
丁酮(NNK)是最丰富和最强的致癌物质之一
含在香烟烟雾中。 NNK诱导高发病率,
实验室啮齿类动物肺中的外周腺癌
在环境空气条件下,
神经内分泌分化时给予高氧仓鼠。
已经证明NNK与烟碱胆碱能和β-肾上腺素能结合,
仓鼠肺和肺癌细胞系中的受体
拟研究NNK对有丝分裂信号转导的影响
由这些受体类型刺激的通路。 具体目标
已经表明NNK诱导的源自于
周围型肺腺癌与β肾上腺素能受体结合
受体(b-AR)和环AMP的激活,Schuller博士将研究
NNK对该信号转导通路的急性和慢性作用
体外使用正常和NNK转化的人支气管细胞,
正常仓鼠Clara细胞以及来源于人的细胞系,
仓鼠肺腺癌作为模型系统。
英文摘要
DESCRIPTION: Neuroendocrine cancer and peripheral adenocarcinoma are the
most common histological lung cancer types linked with smoking. The
nicotine-derived nitrosamine, 4-(methylnitrosamino)-1-(2-pyridyl)-1-
butanone (NNK) is among the most abundant and potent carcinogens
contained in cigarette smoke. NNK induces a high incidence of
peripheral adenocarcinomas in the lungs of laboratory rodents maintained
under ambient air conditions while it causes lung cancers of
neuroendocrine differentiation when administered to hyperoxic hamsters.
Having shown that NNK binds to nicotinic cholinergic and beta-adrenergic
receptors in hamster lung and lung cancer cell lines Dr. Schuller
proposes to study the effects of NNK on mitogenic signal transduction
pathways stimulated by these receptor types. Specific Aim
Having shown that NNK-induced mitogenesis of cell lines derived from
peripheral pulmonary adenocarcinomas involves binding to beta adrenergic
receptors (b-AR) and activation of cyclic AMP, Dr. Schuller will study
the acute and chronic effects of NNK on this signal transduction pathway
in vitro using normal and NNK transformed human bronchial cells and
normal hamster Clara cells as well as cell lines derived from human and
hamster lung adenocarcinomas as model systems.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Activation of voltage-operated Ca2+-channels in human small cell lung carcinoma by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
烟草特异性亚硝胺 4-(甲基亚硝基氨基)-1-(3-吡啶基)-1-丁酮激活人小细胞肺癌中的电压操作 Ca2+通道。
DOI:
10.3892/ijo.16.3.513
发表时间:
2000
期刊:
International journal of oncology
影响因子:
5.2
作者:
[Sheppard,BJ, Williams,M, Plummer,HK, Schuller,HM]
通讯作者:
Schuller,HM
DOI:
--
发表时间:
1999-09
期刊:
Cancer research
影响因子:
11.2
作者:
[H. Schuller;P. Tithof;Michelle A Williams;H. Plummer]
通讯作者:
H. Schuller;P. Tithof;Michelle A Williams;H. Plummer
DOI:
10.3892/ijo.19.3.445
发表时间:
2001-09
期刊:
International journal of oncology
影响因子:
5.2
作者:
[H. Schuller;H. Plummer;P. Bochsler;Paul Dudric;J. Bell;Randall Harris]
通讯作者:
H. Schuller;H. Plummer;P. Bochsler;Paul Dudric;J. Bell;Randall Harris
DOI:
--
发表时间:
1995
期刊:
Cancer research
影响因子:
11.2
作者:
[P. Park;J. Merryman;M. Orloff;H. Schuller]
通讯作者:
P. Park;J. Merryman;M. Orloff;H. Schuller
DOI:
10.1186/1465-9921-6-29
发表时间:
2005-04-04
期刊:
Respiratory research
影响因子:
5.8
作者:
[Plummer HK 3rd, Dhar M, Schuller HM]
通讯作者:
Schuller HM
共 7 条
The GABA-B receptor is a novel drug target for pancreatic cancer
-
批准号:8064258
-
项目类别:
-
资助金额:$26.45万
-
财政年份:2009
-
负责人:Hildegard M. Schuller
-
依托单位:
Modulation of cancer prevention by social stress
-
批准号:7809021
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Hildegard M. Schuller
-
依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
-
批准号:8252196
-
项目类别:
-
资助金额:$26.45万
-
财政年份:2009
-
负责人:Hildegard M. Schuller
-
依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
-
批准号:7714157
-
项目类别:
-
资助金额:$27.27万
-
财政年份:2009
-
负责人:Hildegard M. Schuller
-
依托单位:
Modulation of cancer prevention by social stress
-
批准号:7937956
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Hildegard M. Schuller
-
依托单位:
The GABA-B receptor is a novel drug target for pancreatic cancer
-
批准号:7872882
-
项目类别:
-
资助金额:$27.27万
-
财政年份:2009
-
负责人:Hildegard M. Schuller
-
依托单位:
Preclin. model for prevention of NSCLC in former smokers
-
批准号:6613046
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2003
-
负责人:Hildegard M. Schuller
-
依托单位:
Preclin. model for prevention of NSCLC in former smokers
-
批准号:6744372
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2003
-
负责人:Hildegard M. Schuller
-
依托单位:
Preclin. model for prevention of NSCLC in former smokers
-
批准号:6895771
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2003
-
负责人:Hildegard M. Schuller
-
依托单位:
Preclin. model for prevention of NSCLC in former smokers
-
批准号:7285066
-
项目类别:
-
资助金额:$3.16万
-
财政年份:2003
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK, Beta-Adrenergic AA Release and Lung Cancer
-
批准号:6721254
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2002
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK, Beta-Adrenergic AA Release and Lung Cancer
-
批准号:6874971
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2002
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK, Beta-Adrenergic AA Release and Lung Cancer
-
批准号:6470444
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2002
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK, Beta-Adrenergic AA Release and Lung Cancer
-
批准号:6623847
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2002
-
负责人:Hildegard M. Schuller
-
依托单位:
FACS VANTAGE SE CELL SORTER/FLOW CYTOMETER
-
批准号:6053811
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2000
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK EFFECTS ON RECEPTOR PATHWAYS IN LUNG CELLS
-
批准号:2094195
-
项目类别:
-
资助金额:$19.12万
-
财政年份:1994
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK EFFECTS ON RECEPTOR PATHWAYS IN LUNG CELLS
-
批准号:2094196
-
项目类别:
-
资助金额:$20.0万
-
财政年份:1994
-
负责人:Hildegard M. Schuller
-
依托单位:
NNK EFFECTS ON RECEPTOR PATHWAYS IN LUNG CELLS
-
批准号:2094197
-
项目类别:
-
资助金额:$20.8万
-
财政年份:1994
-
负责人:Hildegard M. Schuller
-
依托单位:
MECHANISMS OF NEUROENDOCRINE LUNG CARCINOGENESIS
-
批准号:3509571
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1991
-
负责人:Hildegard M. Schuller
-
依托单位:
CHARACTERIZATION OF INDUCED NEUROENDOCRINE LUNG CANCER
-
批准号:3191898
-
项目类别:
-
资助金额:$14.56万
-
财政年份:1988
-
负责人:Hildegard M. Schuller
-
依托单位:
海外基金